SCHEMBL6600381

SCHEMBL6600381

Cc1c(C(=O)O)c(-c2cccc3ccccc23)cn1C(Cc1ccc2c(c1)OCO2)c1cnc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 7/20 0.41
FNTB P49356 7/20 0.41
PGGT1B P53609 4/20 0.41
CYP3A4 P08684 1/20 0.41
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 4/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
EDNRB P24530 1/20 0.35
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
ALOX12 P18054 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601970 0.92 FNTA (0.41) FNTAFNTBPGGT1BCYP3A4ALDH1A1
SCHEMBL6599881 0.90 FNTA (0.39) FNTAFNTBPGGT1BCYP3A4ALDH1A1
SCHEMBL6598190 0.89 FNTA (0.52) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6599899 0.84 FNTA (0.42) FNTAFNTBPGGT1BCYP3A4ALDH1A1
SCHEMBL6598939 0.82 FNTA (0.51) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6596847 0.81 FNTA (0.49) FNTAFNTBPGGT1BCYP3A4MAPT
SCHEMBL6600150 0.78 FNTA (0.38) FNTAFNTBPGGT1BCYP3A4ALDH1A1
SCHEMBL4955195 0.77 FNTA (0.60) FNTAFNTBPGGT1BCYP3A4ALDH1A1
SCHEMBL6978530 0.77 FNTA (0.52) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6977268 0.77 FNTA (0.59) FNTAFNTBPGGT1BCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US disclosed